Effects of Amitriptyline on Gastric Sensorimotor Function and Postprandial Symptoms in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial

Bouras, Ernest P.; Talley, Nicholas J.; Camilleri, Michael; Burton, Duane D.; Heckman, Michael G.; Crook, Julia E.; Richelson, Elliott
August 2008
American Journal of Gastroenterology;Aug2008, Vol. 103 Issue 8, p2043
Academic Journal
BACKGROUND: Low-dose tricyclic antidepressants have been used to treat chronic somatic and gastrointestinal pain disorders, including refractory functional dyspepsia. However, there are only limited data on the effects of these drugs on upper gastrointestinal function. AIM: To compare the effects of two doses of amitriptyline (AMT) and placebo on gastric accommodation, emptying, satiation, and postprandial symptoms in healthy volunteers. METHODS: Using a parallel-group, double-blind, placebo-controlled design, 41 healthy volunteers were randomized to AMT 25 mg, AMT 50 mg, or placebo for 2 wk. During the final 3 days of therapy, the following end points were assessed: fasting and postprandial gastric volumes, 2- and 4-h gastric emptying, time and volume to maximum satiation using a nutrient drink test, and postprandial symptoms 30 min later using 10-cm visual analog scales. AMT and metabolite levels were measured. RESULTS: AMT slowed gastric emptying at 2 h (median 75% for placebo, 57% for AMT 25 mg, 67% for AMT 50 mg; P= 0.037) and 4 h (median 98% for placebo, 96% for AMT 25 mg, 92% for AMT 50 mg; P= 0.003). AMT did not affect gastric volumes or satiation volume, but it did reduce nausea scores at 30 min in a dose-dependent manner (median 2.1 for placebo, 0.9 for AMT 25 mg, and 0.0 for AMT 50 mg; P= 0.009). CONCLUSION: In healthy volunteers, AMT slows gastric emptying of solids, but it does not significantly affect gastric volumes or satiation. AMT reduces nausea after challenge with a high calorie liquid load.


Related Articles

  • Hypnosis For the Gut.  // Tufts University Health & Nutrition Letter;Aug2003, Vol. 21 Issue 6, p1 

    Presents a study which investigated the therapeutic effect of hypnotherapy on relieving chronic indigestion. Information on the use of ranitidine and placebo pill; Analysis of findings on hypnotherapy; Physiological effect of anxiety on gastrointestinal problems.

  • Omeprazole and placebo have same long-term effect on dyspepsia. Lepsch, Mark; Strayer, Scott // Journal of Family Practice;Sep2003, Vol. 52 Issue 9, p687 

    The article presents a study which compared the effect of omeprazole and placebo on dyspepsia. Symptoms were relieved in about half of patients receiving omeprazole. However, treatment did not reduce the number of patients who would need endoscopy to investigate the cause of dyspepsia. The...

  • Effect of Amitryptiline on Symptoms, Sleep, and Visceral Perception in Patients With Functional Dyspepsia. Mertz, H.; Fass, R.; Kodner, A.; Yan-Go, F.; Fullerton, S.; Mayer, E. A. // American Journal of Gastroenterology;Feb1998, Vol. 93 Issue 2, p160 

    Objective: Tricyclic antidepressants in low doses are widely used in the therapy of patients with functional gastrointestinal disorders, yet the mechanism(s) of action of these drugs in these disorders is not known. In the current study, we sought to determine in a group of patients with...

  • Gastric Myoelectrical Activity and Gastric Emptying in Patients With Functional Dyspepsia. Zhiyue Lin; Eaker, Ervin Y.; Sarosiek, Irene; McCallum, Richard W. // American Journal of Gastroenterology;Sep1999, Vol. 94 Issue 9, p2384 

    OBJECTIVES: The aims of this study were to investigate gastric myoelectrical activity and gastric emptying (GE) and their relationship in patients with functional dyspepsia. METHODS: The study was conducted in 15 healthy volunteers (six women, nine men, mean age: 42 yr) and 15 patients (13...

  • dyspepsia.  // Royal Society of Medicine: Medicines;2002, p220 

    This article presents a definition for the term "dyspepsia" or indigestion, which refers to disturbed digestion, characterized by discomfort or pain in the region of the stomach or lower chest after eating.

  • Mosapride. Curran, Monique P.; Robinson, Dean M. // Drugs;2008, Vol. 68 Issue 7, p981 

    Mosapride was effective in improving overall symptoms in patients with gastrointestinal disorders, including chronic gastritis, gastro-oesophageal reflux disease and functional dyspepsia. Mosapride was more effective than teprenone in improving gastric stasis symptoms and gastric pain after 2...

  • Valdecoxib Is Associated with Improved Dyspepsia-Related Health Compared with Nonspecific NSAIDs in Patients with Osteoarthritis or Rheumatoid Arthritis. Rabeneck, Linda; Goldstein, Jay L.; Vu, An; Mayne, Tracy J.; Rublee, Dale A. // American Journal of Gastroenterology;May2005, Vol. 100 Issue 5, p1043 

    OBJECTIVES: Dyspepsia and related gastrointestinal (GI) symptoms are commonly reported by patients taking nonspecific nonsteroidal anti-inflammatory drugs (NSAIDs) and significantly impact treatment effectiveness, cost, and quality of life. This study sought to evaluate dyspepsia-related health...

  • PANTS TOO TIGHT? Sathicq, Larraine // Good Medicine (Australian Consolidated Press);Aug2002, p30 

    Discusses the different causes of bloating and their corresponding remedies. Food effects; Drug reactions; Air Travel; Hormones.

  • Potential causes of heartburn. Hashmi, Taqi // Independent Nurse;6/1/2009, p39 

    The article discusses heartburn, dyspepsia, and the gastrointestinal (GI) disorders that may cause them. The GI disorders that are primarily associated with the symptoms of heartburn or dyspepsia include gastric reflux disease (GORD), peptic ulcer, and non-ulcer dyspepsia. The author explores...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics